GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » PEG Ratio

Bristol-Myers Squibb Co (LTS:0R1F) PEG Ratio : 2.00 (As of Dec. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Bristol-Myers Squibb Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Bristol-Myers Squibb Co's PE Ratio without NRI is 49.04. Bristol-Myers Squibb Co's 5-Year EBITDA growth rate is 24.50%. Therefore, Bristol-Myers Squibb Co's PEG Ratio for today is 2.00.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Bristol-Myers Squibb Co's PEG Ratio or its related term are showing as below:

LTS:0R1F' s PEG Ratio Range Over the Past 10 Years
Min: 0.29   Med: 0.77   Max: 12.95
Current: 1.98


During the past 13 years, Bristol-Myers Squibb Co's highest PEG Ratio was 12.95. The lowest was 0.29. And the median was 0.77.


LTS:0R1F's PEG Ratio is ranked worse than
51.51% of 365 companies
in the Drug Manufacturers industry
Industry Median: 1.95 vs LTS:0R1F: 1.98

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Bristol-Myers Squibb Co PEG Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co PEG Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 0.68 2.22 0.52 0.30

Bristol-Myers Squibb Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.30 3.41 3.48 11.28

Competitive Comparison of Bristol-Myers Squibb Co's PEG Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's PEG Ratio falls into.



Bristol-Myers Squibb Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Bristol-Myers Squibb Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=49.038461538462/24.50
=2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Bristol-Myers Squibb Co  (LTS:0R1F) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Bristol-Myers Squibb Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines